Quantbot Technologies LP Sells 23,692 Shares of Maximus, Inc. $MMS

Key Points

• Quantbot Technologies LP reduced its stake in Maximus, Inc. by 57.1%, selling 23,692 shares and holding 17,808 shares worth approximately $1.21 million at the end of the first quarter.
• Several hedge funds significantly increased their holdings in Maximus during the first quarter, with Caitong International Asset Management increasing its position by 17,533.3%.
• Maximus recently reported earnings of $2.16 EPS, exceeding estimates, and declared a quarterly dividend of $0.30 per share with a 1.4% yield.

Quantbot Technologies LP lessened its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 57.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 17,808 shares of the health services provider's stock after selling 23,692 shares during the period. Quantbot Technologies LP's holdings in Maximus were worth $1,214,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Caitong International Asset Management Co. Ltd increased its position in Maximus by 17,533.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock valued at $36,000 after acquiring an additional 526 shares during the last quarter. UMB Bank n.a. increased its position in Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after acquiring an additional 250 shares during the last quarter. GAMMA Investing LLC increased its position in Maximus by 67.1% during the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after acquiring an additional 294 shares during the last quarter. NBC Securities Inc. increased its position in Maximus by 114,900.0% during the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock valued at $78,000 after acquiring an additional 1,149 shares during the last quarter. Finally, Blue Trust Inc. increased its position in Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after acquiring an additional 303 shares during the last quarter. Institutional investors own 97.21% of the company's stock.

Insider Activity at Maximus

In other news, Director Gayathri Rajan sold 7,913 shares of the company's stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the transaction, the director directly owned 14,205 shares in the company, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.60% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th. One research analyst has rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $90.00.

Maximus Trading Up 1.8%

NYSE MMS opened at $86.9260 on Friday. The company's 50-day moving average price is $74.51 and its 200-day moving average price is $71.07. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. The stock has a market cap of $4.90 billion, a PE ratio of 16.01 and a beta of 0.60. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.94.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. The firm had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The business's revenue for the quarter was up 2.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. Maximus's dividend payout ratio is presently 22.10%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.